December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DataMeds AI, Inc. - Common Stock (NQ:MEDS)

2.250 +0.020 (+0.90%)
Delayed Quote Updated: 10:52 AM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DataMeds AI, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmacies To be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026 Program will aim to bring best... 
From DataMEDS AI, Inc.
Via ACCESS Newswire
DefenseNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT)Signs Letter of Intent to Acquire 19.9% Stake in DataMEDS AI (NASDAQ: MEDS)
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion in 2025 to $93.4 billion in 2035 Customer Acquisition Plan... 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds Regains Compliance With NASDAQ Listing Standards
From DataMEDS AI, Inc.
Via ACCESS Newswire
Premarket Movers Oct. 19: Disc Medicine Jumps 51.62%, Rubico Falls 33.84% ↗
Via Chartmill
News headline image
DataMeds Applauds FDA’s Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health’s Peptides Roadmap
DataMeds AI, Inc. (NASDAQ:MEDS) today applauded the issuance of a new policy proposal by the U.S. Food and Drug Administration (FDA) entitled “Interim Access Policy for Compounding Using Certain... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS Si Licenses U.S. Rights To Reboot Health AI’s Direct-To-Consumer GLP-1 Weight Management Platform
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that it has entered into an exclusive license, revenue sharing and marketing agreement with REBOOT Health AI, Inc. (“REBOOT”) for Direct-to-Consumer... 
Via B2i Digital
Topics Artificial Intelligence Intellectual Property
News headline image
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Platform to be integrated into Health Lives Here app as a subscription offering 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that it has implemented cost control measures, primarily through reductions in corporate management positions, to focus the workforce spend on... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx ® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx® Assay In Gynecologic Cancers
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in... 
Via B2i Digital
Topics Artificial Intelligence
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Humana adds ChemoFx ® to its Medicaid Pharmacogenomics Testing coverage policy 
From DataMEDS AI, Inc.
Via ACCESS Newswire
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that it has filed DBAs for ‘DataMEDS SI’ and ‘Corexa Health SI’. 
Via B2i Digital
Topics Artificial Intelligence
News headline image
Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
Healthcare IT Company and its Subsidiary Undertake Action Following US Government's Updated Nomenclature 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DarkHorse CEO Details AI Infrastructure Strategy as DRK Targets Sub-50 MW Compute Opportunity
Via AB Newswire
Topics Artificial Intelligence
News headline image
DataMeds AI’s Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
DataMeds AI, Inc. (NASDAQ:MEDS), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI and Tollo Health Announce Launch of ‘Health Lives Here’ Mobile Application
DataMeds AI, Inc. (NASDAQ:MEDS), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
DataMeds AI, Inc. (NASDAQ:MEDS) announced that its Interim Co-CEO Gerald Commissiong will present “What Patients Really Want” at this year’s National Telehealth and Virtual Care Summit in Las Vegas on... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Unveils New Corporate Website
DataMEDS AI, Inc. (NASDAQ:MEDS) (the “Company” or “DataMEDS”), a Health IT company vertically integrating health data acquisition and transfer, today announced that it launched its new corporate... 
Via B2i Digital
Topics Artificial Intelligence Retirement
News headline image
DataMEDS AI Unveils New Corporate Website
Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
Small-Cap Stocks VEEA, ANY, MEDS, MYSZ Watch Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scaling GPU-as-a-Service business 
From Axe Compute Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.